Crohn’s Disease and Ulcerative Colitis Patient Perspectives on Clinical Trials and Participation

May 7, 2018

Clinical trial recruitment is the biggest barrier to the development and approval of new treatments.

In order to understand patient perceptions and improve recruitment, the Crohn's & Colitis Foundation conducted in-person focus groups over a four-month period in 2016, the results of which are published in the paper "Crohn’s disease and ulcerative colitis patient perspectives on clinical trials and participation."

Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends going to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance ( and the American Institute of Philanthropy (

733 Third Avenue, Suite 510, New York, NY 10017    |    800-932-2423    |
Powered by Blackbaud
nonprofit software